Dexcom announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria. Expanding coverage for rtCGM to include all eligible patients with type 1 or type 2 diabetes establishes Manitoba as the leader among Canadian provinces. As of this announcement, Manitoba is currently the only province in Canada that does not require an application for preapproval of coverage which means improved access for patients and reduced workload for prescribers. The ease of access for rtCGM systems is now raising the bar for other jurisdictions across Canada to follow suit.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DXCM:
- DexCom has no material exposure to developments at Silicon Valley Bank
- DexCom pullback on Abbott news a buying opportunity, says Jefferies
- BofA says buy DexCom on weakness after Abbott’s Libre gets pump integration
- DexCom down more than 7% after FDA gives nod to Abbott CGM sensors
- DexCom put volume heavy and directionally bearish